Jun 15, 2023 / 03:40PM GMT
Andrea R. Tan - Goldman Sachs Group, Inc., Research Division - Research Analyst
Thanks everyone for joining us today on the last day of 44th Annual Goldman Sachs Healthcare Conference. I'm Andrea Tan, one of the biotech analysts here, and I'm super pleased to have the team from Precision BioSciences, Alex Kelly, CFO; Cassie Gorsuch, VP, Gene Therapy. Thank you both for joining us.
John Alexander Kelly - Precision BioSciences, Inc. - CFO
Welcome.
Questions and Answers:
Andrea R. Tan - Goldman Sachs Group, Inc., Research Division - Research AnalystAlex, maybe I'll start with you. You recently had a data update for your allo CAR T program. Walk us through -- and it was extensive, but walk us through here what you presented.
John Alexander Kelly - Precision BioSciences, Inc. - CFO
Okay. Great. Thanks, Andrea. So yes, last on May 31, we had a full update on our CAR-T -- allogeneic CAR T programs. First, we provided an update on azer-cell, which is our lead program in